Yeast susceptibility testing: reference methods and commercial test systems
- 1 September 2001
- journal article
- Published by Elsevier in Clinical Microbiology Newsletter
- Vol. 23 (17) , 131-135
- https://doi.org/10.1016/s0196-4399(01)99001-4
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Fluconazole Disk Diffusion Test with Methylene Blue- and Glucose-Enriched Mueller-Hinton Agar for Determining Susceptibility of Candida SpeciesJournal of Clinical Microbiology, 2001
- Practice Guidelines for the Treatment of CandidiasisClinical Infectious Diseases, 2000
- Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.Journal of Antimicrobial Chemotherapy, 1998
- Comparison of a 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2 H -Tetrazolium Hydroxide (XTT) Colorimetric Method with the Standardized National Committee for Clinical Laboratory Standards Method of Testing Clinical Yeast Isolates for Susceptibility to Antifungal AgentsJournal of Clinical Microbiology, 1998
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- An evaluation of seven methods of testing in vitro susceptibility of clinical yeast isolates to fluconazoleMycoses, 1995
- Evaluation of five commercial antifungal susceptibility testing systemsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993